Colgate-Palmolive Company
$88.77
The Read: 9% due to macroeconomic headwinds and volatility, remained flat on in-line Q1 2026 results, and traded flat on mixed Q2 performance despite beating Base Business EPS, with median moves of ~7%.
No Data
The Stats
Scouting Reports

The Thermal Bottleneck: Pricing the Liquid Cooling Cycle
Aug 27, 2026
The physical limits of standard data center architecture are finally colliding with the ambition of next-generation silicon. For two decades, cooling a server farm was a brute-force exercise in moving
Read more →
Pricing the Pharma Patent Cliff: The AI Biotech Outsourcing Trade
Aug 25, 2026
The latest breakthrough in personalized cancer treatments isn’t just a win for oncology—it is the opening bell for a massive capital reallocation. Staring down a catastrophic wave of late-2020s patent
Read more →
OPEC Fracture and Supply Shocks Drive Upstream E&P Supercycle
May 16, 2026
The global energy market is undergoing a structural realignment that is fundamentally altering capital flows across the broader economy. Following the United Arab Emirates’ departure from OPEC on May
Read more →